chilles Therapeutics, VascVersa, and pHion Therapeutics, with the facility now expanding its operations into Northern Ireland. NA-ATTC is a collaboration of 20 industrial, NHS, and academic organizations that was established in 2018 with the goal of delivering advanced therapy medicinal products (ATMPs) to the North of England and Scotland before making it available to the rest of the country.
Achilles Therapeutics is a clinical-stage biopharmaceutical business focused on the production of precision T cell treatments directed against clonal neoantigens, which are protein markers specific to a patient’s cancer cells. Two Phase I/IIa studies are now underway for advanced non-small cell lung cancer (NSCLC) and metastatic melanoma.
pHion Therapeutics, located in Belfast, is a drug delivery technology business focused on…
